Pharmachologic effect Doxee
Semisynthetic tetracycline, a bacteriostatic broad-spectrum antibiotic derived from metacycline. Penetrating into the cell, acts on intracellularly located pathogens. Inhibits protein synthesis in the microbial cell, disrupting the association of transport aminoacyl-RNA with 30S ribosomal membrane subunits. Doxee Does not affect the synthesis of the cell wall of bacteria. It is highly sensitive: Gram-positive microorganisms Staphylococcus spp. (including Staphylococcus aureus, Staphylococcus albus), Streptococcus spp. (including Streptococcus pneumoniae), Clostridium spp., Listeria spp .; and Gram-negative microorganisms: Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae, Klebsiella spp., Entamoeba histolytica, E.coli, Shigella spp., Enterobacter, Salmonella spp., Pasterella spp., Bacteros, as a way to use the systems for the use of the counters, to use the systems to work for a while. (including strains resistant to other antibiotics, for example, to modern penicillins and cephalosporins). The most sensitive are Haemophilius influenzae (91-96%) and intracellular pathogens.
Indications for use Doxee
Infectious and inflammatory diseases caused by susceptible microorganisms: respiratory tract infections (pharyngitis, acute and chronic bronchitis, tracheitis, bronchopneumonia, lobar pneumonia, lung abscess, pleural empyema); infections of upper respiratory tract (otitis, tonsillitis, sinusitis, etc.); infections of the genitourinary system (cystitis, pyelonephritis, prostatitis, urethritis, urethrocystitis, urogenital mycoplasmosis, endometritis, endocervicitis, acute orchiepididymitis; gonorrhea); infections of the biliary tract and gastrointestinal tract (cholecystitis, cholangitis, gastroenterocolitis, bacterial dysentery, diarrhea "travelers"); infections of the skin and soft tissues (cellulitis, abscesses, furunculosis, panaritiums, infected burns, wounds, etc.); infectious diseases of the eye, syphilis, frambesia, yersiniosis, legionellosis, rickettsiosis, chlamydia of various localization (including prostatitis and proctitis), Q fever, spotty fever of rocky mountains, typhoid fever (including sypha, tick-borne recurrence), borreliosis , bacillary and amebic dysentery, tularemia, cholera, Lyme disease (stage I), actinomycosis, malaria, leptospirosis, trachoma, psittacosis, ornithosis, granulocytic ehrlichiosis; whooping cough, brucellosis, osteomyelitis; sepsis, subacute septic endocarditis, peritonitis. Prevention of postoperative purulent complications; malaria caused by Plasmodium falciparum during short-term travel (less than 4 months) in an area where chloroquine and / or pyrimethamine-sulfadoxine resistant strains are common.
|Package||100mg (30 capsules)|